Cargando…
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response
Our earlier reports demonstrated that Cynomolgus macaques vaccinated with either inactivated partially purified simian immunodeficiency virus (SIV), fixed SIV-infected C8166 (a human T lymphoblastoid cell line) cells, or fixed uninfected C8166 cells can be protected against a challenge infection wit...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2119400/ https://www.ncbi.nlm.nih.gov/pubmed/1402662 |
Ejemplares similares
-
T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian- human immunodeficiency virus
Publicado: (1995) -
Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells
Publicado: (1994) -
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus
por: Zhao, Fangzhu, et al.
Publicado: (2022) -
CD24Fc protects against viral pneumonia in simian immunodeficiency virus-infected Chinese rhesus monkeys
por: Tian, Ren-Rong, et al.
Publicado: (2020) -
Seroprevalence of simian immunodeficiency virus in wild and captive born Sykes' monkeys (Cercopithecus mitis) in Kenya
por: Ellis, Brett R, et al.
Publicado: (2004)